2,271 press releases in English indexed under biotech & pharma.
Partnership pairs ALCMI's international lung cancer research network with Sophos IRB's specialized oncology IRB expertise. SAN CARLOS, Calif., Oct. 8, 2026 -- The Addario Lung Cancer Medical Institute (ALCMI), an international nonprofit specializing in investigator-initiated...
WARREN, N.J., Oct. 08, 2026 -- Tevogen Inc. (“Tevogen” or the “Company”) (Nasdaq: TVGN), an integrated healthcare enterprise combining biopharma, artificial intelligence, and healthcare services to improve the affordability and accessibility of life-saving medicines, today announced that it has entered into a signed, non-exclusive, non-binding Letter of Intent (“LoI”) to evaluate a potential transaction with HRK Healthcare LLC (“HRK”).
LOS ANGELES, Oct. 8, 2026 -- More than 5,000 ear, nose and throat specialists from around the world will gather in Los Angeles next week for the American Academy of Otolaryngology–Head and Neck Surgery's 2026 Annual Meeting & OTO EXPO. The event will feature new research on...
Montreal, Quebec and Vienna, Austria--(October 8, 2026) - Enoumena Therapeutics Inc. and AOP Health today announced an exclusive commercialization agreement to expand Canadian institutional access to PrSIBBORAN® (landiolol hydrochloride), an ultra-short-acting, selective beta-1 adrenergic receptor blocker.Authorized by Health Canada in 2023, SIBBORAN is indicated for the short-term reduction of ventricular rate in patients with supraventricular tachycardia including atrial...
Government-backed research into next-generation psychedelics and neuroplastogens for addictive disorders underscores the continued momentum behind this promising drug class. TAMPA, Fla., Oct. 8, 2026 -- Psilera Inc. ("Psilera"), a leading biopharmaceutical company pioneering...
In a porcine model of severe acute alcohol intoxication, GOA26 demonstrated a rapid reduction in blood alcohol concentration and multi-system biochemical recovery across metabolic, muscle, hematological and liver biomarkers.
Key Takeaways Combined with its Seed round of $8.5M, the company has raised more than $16.5M in support of its activities. Vinci Pharmaceuticals closed an $8+ million Series A financing round to support manufacturing, testing/release activities and first-in-human studies of its EPIPLANT™...
DELRAY BEACH, Fla., Oct. 8, 2026 -- Cyrano Therapeutics, Inc., a clinical-stage regenerative medicine company developing novel treatments for smell and taste disorders, today announced that results from the Phase 2 FLAVOR trial of CYR-064 will open the General Session at the...
October 8, 2026, 7:00 AM CET
Ad Hoc Announcement Pursuant to Art. 53 LR
New York, New York--(October 7, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) between December 29, 2025 and June 29, 2026, both dates inclusive (the "Class Period"), of the important November 2, 2026 lead plaintiff deadline.SO WHAT: If you purchased Unicycive securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs...
SUZHOU, China and MÖLNDAL, Sweden, Oct. 8, 2026 -- Suzhou Ribo Life Science (06938.HK) and its subsidiary Ribocure Pharmaceuticals AB (collectively referred to as "Ribo") announced the successful submission of a Phase Ⅰ Clinical Trial Application (CTA) in EU for RBD3133, a...